{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:06:19Z","timestamp":1794445579321,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Basic Science Research Program through the National Research Foundation of Korea","award":["2018R1D1A1B07049400"],"award-info":[{"award-number":["2018R1D1A1B07049400"]}]},{"name":"Basic Science Research Program through the National Research Foundation of Korea","award":["2018R1D1A1B07045321"],"award-info":[{"award-number":["2018R1D1A1B07045321"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s12149-020-01525-z","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T17:04:03Z","timestamp":1600967043000},"page":"942-951","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Metabolic changes in breast cancer on dual-time-point 18F-FDG PET\/CT imaging according to primary tumor uptake and background parenchymal enhancement"],"prefix":"10.1007","volume":"34","author":[{"given":"Hye Ok","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bom Sahn","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo Young","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-In","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongshin","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeoung Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8752-6280","authenticated-orcid":false,"given":"Hai-Jeon","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,24]]},"reference":[{"key":"1525_CR1","first-page":"1044","volume":"44","author":"S Beaulieu","year":"2003","unstructured":"Beaulieu S, Kinahan P, Tseng J, Dunnwald LK, Schubert EK, Pham P, et al. SUV varies with time after injection in 18F-FDG PET of breast cancer: characterization and method to adjust for time differences. J Nucl Med. 2003;44:1044\u201350.","journal-title":"J Nucl Med"},{"key":"1525_CR2","first-page":"1819","volume":"46","author":"R Kumar","year":"2005","unstructured":"Kumar R, Loving VA, Chauhan A, Zhuang H, Mitchell S, Alavi A. Potential of dual-time-point imaging to improve breast cancer diagnosis with 18F-FDG PET. J Nucl Med. 2005;46:1819\u201324.","journal-title":"J Nucl Med"},{"key":"1525_CR3","first-page":"1440","volume":"47","author":"A Mavi","year":"2006","unstructured":"Mavi A, Urhan M, Yu JQ, Zhuang H, Houseni M, Cermik TF, et al. Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes. J Nucl Med. 2006;47:1440\u20136.","journal-title":"J Nucl Med"},{"key":"1525_CR4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/RLU.0000000000001203","volume":"41","author":"A Dong","year":"2016","unstructured":"Dong A, Wang Y, Lu J, Zuo C. Spectrum of the breast lesions with increased 18F-FDG uptake on PET\/CT. Clin Nucl Med. 2016;41:543\u201357. https:\/\/doi.org\/10.1097\/RLU.0000000000001203.","journal-title":"Clin Nucl Med"},{"key":"1525_CR5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11547-009-0491-6","volume":"115","author":"MG Caprio","year":"2010","unstructured":"Caprio MG, Cangiano A, Imbriaco M, Soscia F, Di Martino G, Farina A, et al. Dual-time-point 18F-FDG PET\/CT in the diagnostic evaluation of suspicious breast lesions. Radiol Med. 2010;115:215\u201324. https:\/\/doi.org\/10.1007\/s11547-009-0491-6.","journal-title":"Radiol Med"},{"key":"1525_CR6","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00259-013-2343-9","volume":"40","author":"G Cheng","year":"2013","unstructured":"Cheng G, Torigian DA, Zhuang H, Alavi A. When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET? Eur J Nucl Med Mol Imaging. 2013;40:779\u201387. https:\/\/doi.org\/10.1007\/s00259-013-2343-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1525_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejrad.2018.11.031","volume":"110","author":"E Kim","year":"2019","unstructured":"Kim E, Mema E, Axelrod D, Sigmund E, Kim SG, Babb J, et al. Preliminary analysis: background parenchymal 18F-FDG uptake in breast cancer patients appears to correlate with background parenchymal enhancement and to vary by distance from the index cancer. Eur J Radiol. 2019;110:163\u20138. https:\/\/doi.org\/10.1016\/j.ejrad.2018.11.031.","journal-title":"Eur J Radiol"},{"key":"1525_CR8","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"WM Association","year":"2013","unstructured":"Association WM. World medical association declaration of helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191\u20134. https:\/\/doi.org\/10.1001\/jama.2013.281053.","journal-title":"JAMA"},{"key":"1525_CR9","unstructured":"Morris EA CC, LEE CH (2013) ACR BI-RADS Atlas\u00ae Magnetic Resonance Imaging. ACR BI-RADS Atlas, Breast Imaging Reporting and Data System. American College of Radiology, Reston, VA."},{"key":"1525_CR10","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2967\/jnumed.107.047787","volume":"49","author":"JW Fletcher","year":"2008","unstructured":"Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008;49:480\u2013508. https:\/\/doi.org\/10.2967\/jnumed.107.047787.","journal-title":"J Nucl Med"},{"key":"1525_CR11","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ejrad.2008.01.045","volume":"70","author":"AA Zytoon","year":"2009","unstructured":"Zytoon AA, Murakami K, El-Kholy MR, El-Shorbagy E, Ebied O. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET\/CT. Eur J Radiol. 2009;70:530\u20138. https:\/\/doi.org\/10.1016\/j.ejrad.2008.01.045.","journal-title":"Eur J Radiol"},{"key":"1525_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1053\/j.semnuclmed.2012.02.003","volume":"42","author":"O Schillaci","year":"2012","unstructured":"Schillaci O. Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity. Semin Nucl Med. 2012;42:267\u201380. https:\/\/doi.org\/10.1053\/j.semnuclmed.2012.02.003.","journal-title":"Semin Nucl Med"},{"key":"1525_CR13","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s12149-015-1013-3","volume":"29","author":"K Shimizu","year":"2015","unstructured":"Shimizu K, Okita R, Saisho S, Yukawa T, Maeda A, Nojima Y, et al. Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer. Ann Nucl Med. 2015;29:854\u201360. https:\/\/doi.org\/10.1007\/s12149-015-1013-3.","journal-title":"Ann Nucl Med"},{"key":"1525_CR14","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2214\/AJR.12.8930","volume":"200","author":"DL Costantini","year":"2013","unstructured":"Costantini DL, Vali R, Chan J, McQuattie S, Charron M. Dual\u2013time-point FDG PET\/CT for the evaluation of pediatric tumors. Am J Roentgenol. 2013;200:408\u201313. https:\/\/doi.org\/10.2214\/AJR.12.8930.","journal-title":"Am J Roentgenol"},{"key":"1525_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12149-012-0669-1","volume":"27","author":"M Nakayama","year":"2013","unstructured":"Nakayama M, Okizaki A, Ishitoya S, Sakaguchi M, Sato J, Aburano T. Dual-time-point 18F- FDG PET\/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions. Ann Nucl Med. 2013;27:163\u20139. https:\/\/doi.org\/10.1007\/s12149-012-0669-1.","journal-title":"Ann Nucl Med"},{"key":"1525_CR16","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/MNM.0b013e32836089ab","volume":"34","author":"R Abgral","year":"2013","unstructured":"Abgral R, Le Roux PY, Rousset J, Querellou S, Valette G, Nowak E, et al. Prognostic value of dual-time-point 18F-FDG PET-CT imaging in patients with head and neck squamous cell carcinoma. Nucl Med Commun. 2013;34:551\u20136. https:\/\/doi.org\/10.1097\/MNM.0b013e32836089ab.","journal-title":"Nucl Med Commun"},{"key":"1525_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.remn.2011.10.006","volume":"31","author":"D Fuster","year":"2012","unstructured":"Fuster D, Lafuente S, Setoain X, Navales I, Perissinotti A, Pavia J, et al. Dual-time point images of the liver with 18F-FDG PET\/CT in suspected recurrence from colorectal cancer. Rev Esp Med Nucl Imagen Mol. 2012;31:111\u20136. https:\/\/doi.org\/10.1016\/j.remn.2011.10.006.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"1525_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1967\/s002449910511","volume":"20","author":"B Wu","year":"2017","unstructured":"Wu B, Zhao Y, Zhang Y, Tan H, Shi H. Does dual-time-point 18F-FDG PET\/CT scan add in the diagnosis of hepatocellular carcinoma? Hell J Nucl Med. 2017;20:79\u201382. https:\/\/doi.org\/10.1967\/s002449910511.","journal-title":"Hell J Nucl Med"},{"key":"1525_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/RLU.0b013e3182639a58","volume":"38","author":"H-J Yoon","year":"2013","unstructured":"Yoon H-J, Kim S-K, Kim T-S, Im H-J, Lee E, Kim H, et al. New Application of dual point 18F-FDG PET\/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer. Clin Nucl Med. 2013;38:7\u201312. https:\/\/doi.org\/10.1097\/RLU.0b013e3182639a58.","journal-title":"Clin Nucl Med"},{"key":"1525_CR20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2214\/ajr.07.3457","volume":"191","author":"CJ Chen","year":"2008","unstructured":"Chen CJ, Lee BF, Yao WJ, Cheng L, Wu PS, Chu CL, et al. Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5. AJR Am J Roentgenol. 2008;191:475\u20139. https:\/\/doi.org\/10.2214\/ajr.07.3457.","journal-title":"AJR Am J Roentgenol"},{"key":"1525_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.lungcan.2009.05.013","volume":"68","author":"FJ Cloran","year":"2010","unstructured":"Cloran FJ, Banks KP, Song WS, Kim Y, Bradley YC. Limitations of dual time point PET in the assessment of lung nodules with low FDG avidity. Lung Cancer. 2010;68:66\u201371. https:\/\/doi.org\/10.1016\/j.lungcan.2009.05.013.","journal-title":"Lung Cancer"},{"key":"1525_CR22","first-page":"173","volume":"43","author":"T Higashi","year":"2002","unstructured":"Higashi T, Saga T, Nakamoto Y, Ishimori T, Mamede MH, Wada M, et al. Relationship between retention index in dual-phase 18F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J Nucl Med. 2002;43:173\u201380.","journal-title":"J Nucl Med"},{"key":"1525_CR23","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2214\/AJR.07.3439","volume":"191","author":"M Imbriaco","year":"2008","unstructured":"Imbriaco M, Caprio MG, Limite G, Pace L, De Falco T, Capuano E, et al. Dual-time-point 18F-FDG PET\/CT versus dynamic breast MRI of suspicious breast lesions. AJR Am J Roentgenol. 2008;191:1323\u201330. https:\/\/doi.org\/10.2214\/AJR.07.3439.","journal-title":"AJR Am J Roentgenol"},{"key":"1525_CR24","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1186\/s12885-019-6315-8","volume":"19","author":"Y Yamagishi","year":"2019","unstructured":"Yamagishi Y, Koiwai T, Yamasaki T, Einama T, Fukumura M, Hiratsuka M, et al. Dual time point 18F-fluorodeoxyglucose positron emission tomography\/computed tomography fusion imaging (18F-FDG PET\/CT) in primary breast cancer. BMC cancer. 2019;19:1146. https:\/\/doi.org\/10.1186\/s12885-019-6315-8.","journal-title":"BMC cancer"},{"key":"1525_CR25","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.diii.2018.08.011","volume":"99","author":"R Rella","year":"2018","unstructured":"Rella R, Bufi E, Belli P, Contegiacomo A, Giuliani M, Rosignuolo M, et al. Background parenchymal enhancement in breast magnetic resonance imaging: a review of current evidences and future trends. Diagn Interv Imaging. 2018;99:815\u201326. https:\/\/doi.org\/10.1016\/j.diii.2018.08.011.","journal-title":"Diagn Interv Imaging"},{"key":"1525_CR26","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.18.20566","author":"DA Sippo","year":"2019","unstructured":"Sippo DA, Rutledge GM, Burk KS, Mercaldo SF, Dontchos BN, Edmonds CE, et al. Effect of background parenchymal enhancement on cancer risk across different high-risk patient populations undergoing screening breast MRI. AJR Am J Roentgenol. 2019. https:\/\/doi.org\/10.2214\/ajr.18.20566.","journal-title":"AJR Am J Roentgenol"},{"key":"1525_CR27","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2214\/ajr.10.4550","volume":"196","author":"NM Hambly","year":"2011","unstructured":"Hambly NM, Liberman L, Dershaw DD, Brennan S, Morris EA. Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up. AJR Am J Roentgenol. 2011;196:218\u201324. https:\/\/doi.org\/10.2214\/ajr.10.4550.","journal-title":"AJR Am J Roentgenol"},{"key":"1525_CR28","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1200\/jco.18.00378","volume":"37","author":"VA Arasu","year":"2019","unstructured":"Arasu VA, Miglioretti DL, Sprague BL, Alsheik NH, Buist DSM, Henderson LM, et al. Population-based assessment of the association between magnetic resonance imaging background parenchymal enhancement and future primary breast cancer risk. J Clin Oncol. 2019;37:954\u201363. https:\/\/doi.org\/10.1200\/jco.18.00378.","journal-title":"J Clin Oncol"},{"key":"1525_CR29","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s00330-011-2175-6","volume":"21","author":"T Uematsu","year":"2011","unstructured":"Uematsu T, Kasami M, Watanabe J. Does the degree of background enhancement in breast MRI affect the detection and staging of breast cancer? Eur Radiol. 2011;21:2261\u20137. https:\/\/doi.org\/10.1007\/s00330-011-2175-6.","journal-title":"Eur Radiol"},{"key":"1525_CR30","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1148\/radiol.2333031484","volume":"233","author":"WA Berg","year":"2004","unstructured":"Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233:830\u201349. https:\/\/doi.org\/10.1148\/radiol.2333031484.","journal-title":"Radiology"},{"key":"1525_CR31","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.2967\/jnumed.116.174904","volume":"57","author":"D Leithner","year":"2016","unstructured":"Leithner D, Baltzer PA, Magometschnigg HF, Wengert GJ, Karanikas G, Helbich TH, et al. Quantitative assessment of breast parenchymal uptake on 18F-FDG PET\/CT: correlation with age, background parenchymal enhancement, and amount of fibroglandular tissue on MRI. J Nucl Med. 2016;57:1518\u201322. https:\/\/doi.org\/10.2967\/jnumed.116.174904.","journal-title":"J Nucl Med"},{"key":"1525_CR32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2214\/AJR.10.4550","volume":"196","author":"NM Hambly","year":"2011","unstructured":"Hambly NM, Liberman L, Dershaw DD, Brennan S, Morris EA. Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up. Am J Roentgenol. 2011;196:218\u201324. https:\/\/doi.org\/10.2214\/AJR.10.4550.","journal-title":"Am J Roentgenol"},{"key":"1525_CR33","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.2214\/AJR.09.2657","volume":"193","author":"RL Ellis","year":"2009","unstructured":"Ellis RL. Optimal timing of breast mri examinations for premenopausal women who do not have a normal menstrual cycle. Am J Roentgenol. 2009;193:1738\u201340. https:\/\/doi.org\/10.2214\/AJR.09.2657.","journal-title":"Am J Roentgenol"},{"key":"1525_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. Journal of chiropractic medicine. 2016;15:155\u201363. https:\/\/doi.org\/10.1016\/j.jcm.2016.02.012.","journal-title":"Journal of chiropractic medicine"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-020-01525-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-020-01525-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-020-01525-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T05:13:02Z","timestamp":1632460382000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-020-01525-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,24]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1525"],"URL":"https:\/\/doi.org\/10.1007\/s12149-020-01525-z","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,24]]},"assertion":[{"value":"2 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}